Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models
Open Access
- 11 November 2024
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 9 (1) , 1-11
Abstract
Understanding potential differences in vaccine-induced protection between demographic subgroups is key for vaccine development. Vaccine efficacy evaluation across these subgroups in phase 2b or 3 clinical trials presents challenges due to lack of precision: such trials are typically designed to demonstrate overall efficacy rather than to differentiate its value between subgroups. This study proposes a method for estimating vaccine efficacy using immunogenicity (instead of vaccination status) as a predictor in time-to-event models. The method is applied to two datasets from immunogenicity sub-studies of vaccine phase 3 clinical trials for zoster and dengue vaccines. Results show that using immunogenicity-based estimation of efficacy in subgroups using time-to-event models is more precise than the standard estimation. Incorporating immune correlate data in time-to-event models improves precision in estimating efficacy (i.e., yields narrower confidence intervals), which can assist vaccine developers and public health authorities in making informed decisions.Keywords
Funding Information
- Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
- Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
This publication has 61 references indexed in Scilit:
- A Framework for Assessing Immunological Correlates of Protection in Vaccine TrialsThe Journal of Infectious Diseases, 2007
- Augmented Designs to Assess Immune Response in Vaccine TrialsBiometrics, 2006
- A model for immunological correlates of protectionStatistics in Medicine, 2005
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- A note on competing risks in survival data analysisBritish Journal of Cancer, 2004
- Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problemsStatistics in Medicine, 2002
- Principal Stratification in Causal InferenceBiometrics, 2002
- Interpretation and Estimation of Vaccine Efficacy under HeterogeneityAmerican Journal of Epidemiology, 1992
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- A Plaque Reduction Test for Dengue Virus Neutralizing AntibodiesThe Journal of Immunology, 1967